PROB.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 17:40):

Stats
Dzisiejszy wolumen	119.00
Średni wolumen	664.00
Kapitalizacja rynkowa	2.32B
EPS	SEK0 ( 2024-04-23 )
Następna data zysków	( SEK0 ) 2024-07-16
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	137.84
ATR14	SEK0 (0.00%)

Probi AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Probi AB (publ) Finanse

Annual	2023
Przychody:	SEK627.69M
Zysk brutto:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2023
Przychody:	SEK627.69M
Zysk brutto:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2022
Przychody:	SEK618.29M
Zysk brutto:	SEK255.45M (41.32 %)
EPS:	SEK3.57

FY	2021
Przychody:	SEK658.18M
Zysk brutto:	SEK288.01M (43.76 %)
EPS:	SEK7.30

Financial Reports:

No articles found.

Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.